{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:22:55Z","timestamp":1792815775381,"version":"4.5.0"},"reference-count":115,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01NS034239-30"],"award-info":[{"award-number":["5R01NS034239-30"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Extracellular vesicles (EVs) are mediators of neurodegeneration and emerging therapeutic tools for central nervous system disorders. On the one hand, they help spread beta amyloid, tau,\n                    <jats:italic>\u03b1<\/jats:italic>\n                    -synuclein, TDP-43, and mutant SOD1, contributing to the signs and symptoms of Alzheimer\u2019s, Parkinson\u2019s, Amyotrophic lateral sclerosis, and Huntington\u2019s Diseases. By activating glial cells, they promote chronic neuroinflammation through carrying cytokines, inflammasomes, and chemokines. On the other hand, EVs\u2019 ability to transport neuroregulatory products and cross the blood\u2013brain barrier makes them ideal vehicles for drug delivery. Their function can be surface-modified to deliver targeted therapies, including anti-inflammatory and neuroprotective regulatory RNAs, proteins, and lipids, as well as factors that help maintain neural homeostasis. Notably, we suggest that colostrum-derived EVs, enriched with growth factors and immune-regulatory microRNAs, offer a natural, scalable, and biocompatible source for neuroprotective treatment. Although EVs can act as \u201cJanus-faced\u201d entities \u2013 serving both as disease initiators and versatile therapeutic vehicles \u2013 controlling their activity can enable immune-based therapeutics for neurodegenerative diseases.\n                  <\/jats:p>","DOI":"10.1515\/nipt-2025-0016","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T10:56:54Z","timestamp":1766055414000},"page":"377-390","source":"Crossref","is-referenced-by-count":6,"title":["Extracellular vesicle-based therapies for\u00a0neurodegenerative diseases"],"prefix":"10.1515","volume":"4","author":[{"given":"Guoku","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience , 12284 University of Nebraska Medical Center , Omaha , NE , 68198 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gogzheyan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience , 12284 University of Nebraska Medical Center , Omaha , NE , 68198 , USA"},{"name":"Department of Biological Sciences , Northern Kentucky University , Highland Heights , KY , 41099 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudipta","family":"Panja","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience , 12284 University of Nebraska Medical Center , Omaha , NE , 68198 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susmita","family":"Sil","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience , 12284 University of Nebraska Medical Center , Omaha , NE , 68198 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard E.","family":"Gendelman","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Experimental Neuroscience , 12284 University of Nebraska Medical Center , Omaha , NE , 68198 , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"key":"2025123112070696073_j_nipt-2025-0016_ref_001","doi-asserted-by":"crossref","unstructured":"Kumar, MA, Baba, SK, Sadida, HQ, Marzooqi, SA, Jerobin, J, Altemani, FH, et al.. Extracellular vesicles as tools and targets in therapy for diseases. Signal Transduct Targeted Ther 2024;9:27. https:\/\/doi.org\/10.1038\/s41392-024-01735-1.","DOI":"10.1038\/s41392-024-01735-1"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_002","doi-asserted-by":"crossref","unstructured":"Yanez-Mo, M, Siljander, PR, Andreu, Z, Zavec, AB, Borras, FE, Buzas, EI, et al.. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015;4:27066. https:\/\/doi.org\/10.3402\/jev.v4.27066.","DOI":"10.3402\/jev.v4.27066"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_003","doi-asserted-by":"crossref","unstructured":"Hu, G, Drescher, KM, Chen, XM. Exosomal miRNAs: biological properties and therapeutic potential. Front Genet 2012;3:56. https:\/\/doi.org\/10.3389\/fgene.2012.00056.","DOI":"10.3389\/fgene.2012.00056"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_004","doi-asserted-by":"crossref","unstructured":"Xu, D, Di, K, Fan, B, Wu, J, Gu, X, Sun, Y, et al.. MicroRNAs in extracellular vesicles: sorting mechanisms, diagnostic value, isolation, and detection technology. Front Bioeng Biotechnol 2022;10:948959. https:\/\/doi.org\/10.3389\/fbioe.2022.948959.","DOI":"10.3389\/fbioe.2022.948959"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_005","doi-asserted-by":"crossref","unstructured":"Williams, A, Branscome, H, Kashanchi, F, Batrakova, EV. Targeting of extracellular vesicle-based therapeutics to the brain. Cells 2025;14. https:\/\/doi.org\/10.3390\/cells14070548.","DOI":"10.3390\/cells14070548"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_006","doi-asserted-by":"crossref","unstructured":"Sil, S, Dagur, RS, Liao, K, Peeples, ES, Hu, G, Periyasamy, P, et al.. Strategies for the use of extracellular vesicles for the delivery of therapeutics. J Neuroimmune Pharmacol 2019. https:\/\/doi.org\/10.1007\/s11481-019-09873-y.","DOI":"10.1007\/s11481-019-09873-y"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_007","doi-asserted-by":"crossref","unstructured":"Mosley, RL, Benner, EJ, Kadiu, I, Thomas, M, Boska, MD, Hasan, K, et al.. Neuroinflammation, oxidative stress and the pathogenesis of parkinson\u2019s disease. Clin Neurosci Res 2006;6:261\u201381. https:\/\/doi.org\/10.1016\/j.cnr.2006.09.006.","DOI":"10.1016\/j.cnr.2006.09.006"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_008","doi-asserted-by":"crossref","unstructured":"Mosley, RL, Hutter-Saunders, JA, Stone, DK, Gendelman, HE. Inflammation and adaptive immunity in parkinson\u2019s disease. Cold Spring Harb Perspect Med 2012;2:a009381. https:\/\/doi.org\/10.1101\/cshperspect.a009381.","DOI":"10.1101\/cshperspect.a009381"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_009","doi-asserted-by":"crossref","unstructured":"Machhi, J, Kevadiya, BD, Muhammad, IK, Herskovitz, J, Olson, KE, Mosley, RL, et al.. Harnessing regulatory T cell neuroprotective activities for treatment of neurodegenerative disorders. Mol Neurodegener 2020;15:32. https:\/\/doi.org\/10.1186\/s13024-020-00375-7.","DOI":"10.1186\/s13024-020-00375-7"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_010","doi-asserted-by":"crossref","unstructured":"Machhi, J, Yeapuri, P, Lu, Y, Foster, E, Chikhale, R, Herskovitz, J, et al.. CD4+ effector T cells accelerate alzheimer\u2019s disease in mice. J Neuroinflammation 2021;18:272. https:\/\/doi.org\/10.1186\/s12974-021-02308-7.","DOI":"10.1186\/s12974-021-02308-7"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_011","doi-asserted-by":"crossref","unstructured":"Cotter, RL, Burke, WJ, Thomas, VS, Potter, JF, Zheng, J, Gendelman, HE. Insights into the neurodegenerative process of alzheimer\u2019s disease: a role for mononuclear phagocyte-associated inflammation and neurotoxicity. J Leukoc Biol 1999;65:416\u201327. https:\/\/doi.org\/10.1002\/jlb.65.4.416.","DOI":"10.1002\/jlb.65.4.416"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_012","doi-asserted-by":"crossref","unstructured":"Jo, M, Lee, S, Jeon, YM, Kim, S, Kwon, Y, Kim, HJ. The role of TDP-43 propagation in neurodegenerative diseases: integrating insights from clinical and experimental studies. Exp Mol Med 2020;52:1652\u201362. https:\/\/doi.org\/10.1038\/s12276-020-00513-7.","DOI":"10.1038\/s12276-020-00513-7"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_013","doi-asserted-by":"crossref","unstructured":"Wild, EJ, Boggio, R, Langbehn, D, Robertson, N, Haider, S, Miller, JR, et al.. Quantification of mutant huntingtin protein in cerebrospinal fluid from huntington\u2019s disease patients. J Clin Investig 2015;125:1979\u201386. https:\/\/doi.org\/10.1172\/jci80743.","DOI":"10.1172\/JCI80743"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_014","doi-asserted-by":"crossref","unstructured":"Mey, GM, Mahajan, KR, DeSilva, TM. Neurodegeneration in multiple sclerosis. WIREs Mech Dis 2023;15:e1583. https:\/\/doi.org\/10.1002\/wsbm.1583.","DOI":"10.1002\/wsbm.1583"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_015","doi-asserted-by":"crossref","unstructured":"Town, T, Nikolic, V, Tan, J. The microglial \"activation\" continuum: from innate to adaptive responses. J Neuroinflammation 2005;2:24. https:\/\/doi.org\/10.1186\/1742-2094-2-24.","DOI":"10.1186\/1742-2094-2-24"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_016","doi-asserted-by":"crossref","unstructured":"Woodburn, SC, Bollinger, JL, Wohleb, ES. The semantics of microglia activation: neuroinflammation, homeostasis, and stress. J Neuroinflammation 2021;18:258. https:\/\/doi.org\/10.1186\/s12974-021-02309-6.","DOI":"10.1186\/s12974-021-02309-6"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_017","doi-asserted-by":"crossref","unstructured":"Reynolds, AD, Glanzer, JG, Kadiu, I, Ricardo-Dukelow, M, Chaudhuri, A, Ciborowski, P, et al.. Nitrated alpha-synuclein-activated microglial profiling for parkinson\u2019s disease. J Neurochem 2008;104:1504\u201325. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05087.x.","DOI":"10.1111\/j.1471-4159.2007.05087.x"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_018","doi-asserted-by":"crossref","unstructured":"Wu, D, Chen, Q, Chen, X, Han, F, Chen, Z, Wang, Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Targeted Ther 2023;8:217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","DOI":"10.1038\/s41392-023-01481-w"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_019","doi-asserted-by":"crossref","unstructured":"Zlokovic, BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57:178\u2013201. https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003.","DOI":"10.1016\/j.neuron.2008.01.003"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_020","doi-asserted-by":"crossref","unstructured":"Ruan, Z, Pathak, D, Venkatesan Kalavai, S, Yoshii-Kitahara, A, Muraoka, S, Bhatt, N, et al.. Alzheimer\u2019s disease brain-derived extracellular vesicles spread tau pathology in interneurons: Brain. J Neurol 2021;144:288\u2013309. https:\/\/doi.org\/10.1093\/brain\/awaa376.","DOI":"10.1093\/brain\/awaa376"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_021","doi-asserted-by":"crossref","unstructured":"Dellar, ER, Nikel, L, Fowler, S, Vahsen, BF, Dafinca, R, Feneberg, E, et al.. Extracellular vesicles in TDP-43 proteinopathies: pathogenesis and biomarker potential. Mol Neurodegener 2025;20:68. https:\/\/doi.org\/10.1186\/s13024-025-00859-4.","DOI":"10.1186\/s13024-025-00859-4"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_022","doi-asserted-by":"crossref","unstructured":"Hu, G, Yang, L, Cai, Y, Niu, F, Mezzacappa, F, Callen, S, et al.. Emerging roles of extracellular vesicles in neurodegenerative disorders: focus on HIV-Associated neurological complications. Cell Death Dis 2016;7:e2481. https:\/\/doi.org\/10.1038\/cddis.2016.336.","DOI":"10.1038\/cddis.2016.336"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_023","doi-asserted-by":"crossref","unstructured":"Thompson, AG, Gray, E, Heman-Ackah, SM, Mager, I, Talbot, K, Andaloussi, SE, et al.. Extracellular vesicles in neurodegenerative disease - pathogenesis to biomarkers. Nat Rev Neurol 2016;12:346\u201357. https:\/\/doi.org\/10.1038\/nrneurol.2016.68.","DOI":"10.1038\/nrneurol.2016.68"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_024","doi-asserted-by":"crossref","unstructured":"Asai, H, Ikezu, S, Tsunoda, S, Medalla, M, Luebke, J, Haydar, T, et al.. Depletion of microglia and inhibition of exosome synthesis halt tau propagation. Nat Neurosci 2015;18:1584\u201393. https:\/\/doi.org\/10.1038\/nn.4132.","DOI":"10.1038\/nn.4132"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_025","doi-asserted-by":"crossref","unstructured":"Yan, S, Jiang, C, Janzen, A, Barber, TR, Seger, A, Sommerauer, M, et al.. Neuronally derived extracellular vesicle alpha-Synuclein as a serum biomarker for individuals at risk of developing parkinson disease. JAMA Neurol 2024;81:59\u201368. https:\/\/doi.org\/10.1001\/jamaneurol.2023.4398.","DOI":"10.1001\/jamaneurol.2023.4398"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_026","doi-asserted-by":"crossref","unstructured":"Ma, R, Kutchy, NA, Hu, G. Astrocyte-derived extracellular vesicle-mediated activation of primary ciliary signaling contributes to the development of morphine tolerance. Biol Psychiatry 2021;90:575\u201385. https:\/\/doi.org\/10.1016\/j.biopsych.2021.06.009.","DOI":"10.1016\/j.biopsych.2021.06.009"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_027","doi-asserted-by":"crossref","unstructured":"d\u2019Errico, P, Meyer-Luehmann, M. Mechanisms of pathogenic tau and abeta protein spreading in alzheimer\u2019s disease. Front Aging Neurosci 2020;12:265. https:\/\/doi.org\/10.3389\/fnagi.2020.00265.","DOI":"10.3389\/fnagi.2020.00265"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_028","doi-asserted-by":"crossref","unstructured":"Shippey, LE, Campbell, SG, Hill, AF, Smith, DP. Propagation of parkinson\u2019s disease by extracellular vesicle production and secretion. Biochem Soc Trans 2022;50:1303\u201314. https:\/\/doi.org\/10.1042\/bst20220204.","DOI":"10.1042\/BST20220204"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_029","doi-asserted-by":"crossref","unstructured":"Vandendriessche, C, Bruggeman, A, Van Cauwenberghe, C, Vandenbroucke, RE. Extracellular vesicles in alzheimer\u2019s and parkinson\u2019s disease: small entities with large consequences. Cells 2020;9. https:\/\/doi.org\/10.3390\/cells9112485.","DOI":"10.3390\/cells9112485"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_030","doi-asserted-by":"crossref","unstructured":"Carata, E, Muci, M, Di Giulio, S, Di Giulio, T, Mariano, S, Panzarini, E. The neuromuscular disorder mediated by extracellular vesicles in amyotrophic lateral sclerosis. Curr Issues Mol Biol 2024;46:5999\u20136017. https:\/\/doi.org\/10.3390\/cimb46060358.","DOI":"10.3390\/cimb46060358"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_031","doi-asserted-by":"crossref","unstructured":"Silverman, JM, Fernando, SM, Grad, LI, Hill, AF, Turner, BJ, Yerbury, JJ, et al.. Disease mechanisms in ALS: misfolded SOD1 transferred through exosome-dependent and exosome-independent pathways. Cell Mol Neurobiol 2016;36:377\u201381. https:\/\/doi.org\/10.1007\/s10571-015-0294-3.","DOI":"10.1007\/s10571-015-0294-3"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_032","doi-asserted-by":"crossref","unstructured":"Kuang, X, Nunn, K, Jiang, J, Castellano, P, Hardikar, U, Horgan, A, et al.. Structural insight into transmissive mutant huntingtin species by correlative light and electron microscopy and cryo-electron tomography. Biochem Biophys Res Commun 2021;560:99\u2013104. https:\/\/doi.org\/10.1016\/j.bbrc.2021.04.124.","DOI":"10.1016\/j.bbrc.2021.04.124"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_033","doi-asserted-by":"crossref","unstructured":"Ananbeh, H, Novak, J, Juhas, S, Juhasova, J, Klempir, J, Doleckova, K, et al.. Huntingtin Co-Isolates with small extracellular vesicles from blood plasma of TgHD and KI-HD pig models of huntington\u2019s disease and human blood plasma. Int J Mol Sci 2022;23. https:\/\/doi.org\/10.3390\/ijms23105598.","DOI":"10.3390\/ijms23105598"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_034","doi-asserted-by":"crossref","unstructured":"Miguez, A, Gomis, C, Vila, C, Monguio-Tortajada, M, Fernandez-Garcia, S, Bombau, G, et al.. Soluble mutant huntingtin drives early human pathogenesis in huntington\u2019s disease. Cell Mol Life Sci 2023;80:238. https:\/\/doi.org\/10.1007\/s00018-023-04882-w.","DOI":"10.1007\/s00018-023-04882-w"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_035","doi-asserted-by":"crossref","unstructured":"Kwok, ZH, Wang, C, Jin, Y. Extracellular vesicle transportation and uptake by recipient cells: a critical process to regulate human diseases. Processes 2021;9. https:\/\/doi.org\/10.3390\/pr9020273.","DOI":"10.3390\/pr9020273"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_036","doi-asserted-by":"crossref","unstructured":"Gabrielli, M, Raffaele, S, Fumagalli, M, Verderio, C. The multiple faces of extracellular vesicles released by microglia: where are we 10 years after? Front Cell Neurosci 2022;16:984690. https:\/\/doi.org\/10.3389\/fncel.2022.984690.","DOI":"10.3389\/fncel.2022.984690"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_037","doi-asserted-by":"crossref","unstructured":"Ma, R, Chen, L, Hu, N, Caplan, S, Hu, G. Cilia and extracellular vesicles in brain development and disease. Biol Psychiatry 2023. https:\/\/doi.org\/10.1016\/j.biopsych.2023.11.004.","DOI":"10.1016\/j.biopsych.2023.11.004"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_038","doi-asserted-by":"crossref","unstructured":"Claridge, B, Lozano, J, Poh, QH, Greening, DW. Development of extracellular vesicle therapeutics: challenges, considerations, and opportunities. Front Cell Dev Biol 2021;9:734720. https:\/\/doi.org\/10.3389\/fcell.2021.734720.","DOI":"10.3389\/fcell.2021.734720"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_039","doi-asserted-by":"crossref","unstructured":"Ma, R, Chen, L, Hu, G. Extracellular vesicles: therapeutic delivery. In: Neuroimmune pharmacology and therapeutics. Cham: Springer Nature Switzerland; 2024:855\u201371 pp.","DOI":"10.1007\/978-3-031-68237-7_47"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_040","doi-asserted-by":"crossref","unstructured":"Hu, N, Chen, L, Hu, G, Ma, R. Advancements in extracellular vesicle therapy for neurodegenerative diseases. Explor Neuroprotective Ther 2025;5. https:\/\/doi.org\/10.37349\/ent.2025.1004104.","DOI":"10.37349\/ent.2025.1004104"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_041","doi-asserted-by":"crossref","unstructured":"Alvarez-Erviti, L, Seow, Y, Yin, H, Betts, C, Lakhal, S, Wood, MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011;29:341\u20135. https:\/\/doi.org\/10.1038\/nbt.1807.","DOI":"10.1038\/nbt.1807"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_042","doi-asserted-by":"crossref","unstructured":"Chivero, ET, Liao, K, Niu, F, Tripathi, A, Tian, C, Buch, S, et al.. Engineered extracellular vesicles loaded with miR-124 attenuate cocaine-mediated activation of microglia. Front Cell Dev Biol 2020;8:573. https:\/\/doi.org\/10.3389\/fcell.2020.00573.","DOI":"10.3389\/fcell.2020.00573"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_055","doi-asserted-by":"crossref","unstructured":"Huang, M, Long, A, Hao, L, Shi, Z, Zhang, M. Astrocyte in neurological disease: pathogenesis and therapy. MedComm 2020)2025;6:e70299. https:\/\/doi.org\/10.1002\/mco2.70299.","DOI":"10.1002\/mco2.70299"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_056","doi-asserted-by":"crossref","unstructured":"Adamu, A, Li, S, Gao, F, Xue, G. The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets. Front Aging Neurosci 2024;16:1347987. https:\/\/doi.org\/10.3389\/fnagi.2024.1347987.","DOI":"10.3389\/fnagi.2024.1347987"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_057","doi-asserted-by":"crossref","unstructured":"Rostami, A, Ciric, B. Role of Th17 cells in the pathogenesis of CNS inflammatory demyelination. J Neurol Sci 2013;333:76\u201387. https:\/\/doi.org\/10.1016\/j.jns.2013.03.002.","DOI":"10.1016\/j.jns.2013.03.002"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_058","doi-asserted-by":"crossref","unstructured":"Goverman, J. Autoimmune T cell responses in the central nervous system. Nat Rev Immunol 2009;9:393\u2013407. https:\/\/doi.org\/10.1038\/nri2550.","DOI":"10.1038\/nri2550"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_059","doi-asserted-by":"crossref","unstructured":"Sulzer, D, Alcalay, RN, Garretti, F, Cote, L, Kanter, E, Agin-Liebes, J, et al.. T cells from patients with parkinson\u2019s disease recognize alpha-synuclein peptides. Nature 2017;546:656\u201361. https:\/\/doi.org\/10.1038\/nature22815.","DOI":"10.1038\/nature22815"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_060","doi-asserted-by":"crossref","unstructured":"Gilyazova, I, Asadullina, D, Kagirova, E, Sikka, R, Mustafin, A, Ivanova, E, et al.. MiRNA-146a-A key player in immunity and diseases. Int J Mol Sci 2023;24. https:\/\/doi.org\/10.3390\/ijms241612767.","DOI":"10.3390\/ijms241612767"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_061","doi-asserted-by":"crossref","unstructured":"Saba, R, Sorensen, DL, Booth, SA. MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol 2014;5:578. https:\/\/doi.org\/10.3389\/fimmu.2014.00578.","DOI":"10.3389\/fimmu.2014.00578"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_062","doi-asserted-by":"crossref","unstructured":"Fan, W, Liang, C, Ou, M, Zou, T, Sun, F, Zhou, H, et al.. MicroRNA-146a is a wide-reaching neuroinflammatory regulator and potential treatment target in neurological diseases. Front Mol Neurosci 2020;13:90. https:\/\/doi.org\/10.3389\/fnmol.2020.00090.","DOI":"10.3389\/fnmol.2020.00090"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_063","doi-asserted-by":"crossref","unstructured":"Leavitt, RJ, Acharya, MM, Baulch, JE, Limoli, CL. Extracellular vesicle-derived miR-124 resolves radiation-induced brain injury. Cancer Res 2020;80:4266\u201377. https:\/\/doi.org\/10.1158\/0008-5472.can-20-1599.","DOI":"10.1158\/0008-5472.CAN-20-1599"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_064","doi-asserted-by":"crossref","unstructured":"Ponomarev, ED, Veremeyko, T, Barteneva, N, Krichevsky, AM, Weiner, HL. MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C\/EBP-alpha-PU.1 pathway. Nat Med 2011;17:64\u201370. https:\/\/doi.org\/10.1038\/nm.2266.","DOI":"10.1038\/nm.2266"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_065","doi-asserted-by":"crossref","unstructured":"Sun, Y, Luo, ZM, Guo, XM, Su, DF, Liu, X. An updated role of microRNA-124 in central nervous system disorders: a review. Front Cell Neurosci 2015;9:193. https:\/\/doi.org\/10.3389\/fncel.2015.00193.","DOI":"10.3389\/fncel.2015.00193"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_066","doi-asserted-by":"crossref","unstructured":"Asl, ER, Hosseini, SE, Tahmasebi, F, Bolandi, N, Barati, S. MiR-124 and MiR-155 as therapeutic targets in microglia-mediated inflammation in multiple sclerosis. Cell Mol Neurobiol 2025;45:63. https:\/\/doi.org\/10.1007\/s10571-025-01578-6.","DOI":"10.1007\/s10571-025-01578-6"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_067","doi-asserted-by":"crossref","unstructured":"Bai, X, Bian, Z. MicroRNA-21 is a versatile regulator and potential treatment target in central nervous system disorders. Front Mol Neurosci 2022;15:842288. https:\/\/doi.org\/10.3389\/fnmol.2022.842288.","DOI":"10.3389\/fnmol.2022.842288"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_068","doi-asserted-by":"crossref","unstructured":"Lv, X, Liang, J, Wang, Z. MiR-21-5p reduces apoptosis and inflammation in rats with spinal cord injury through PI3K\/AKT pathway. Panminerva Med 2024;66:256\u201365. https:\/\/doi.org\/10.23736\/s0031-0808.20.03974-9.","DOI":"10.23736\/S0031-0808.20.03974-9"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_069","unstructured":"Zhang, J, He, S, Xiao, Q, Jiang, W, Wang, B, Lu, J, et al.. Engineered mesenchymal stem cell-derived extracellular vesicles overexpressing miR-146a alleviate neuroinflammation in alzheimer\u2019s disease. Neural Regen Res 2025. https:\/\/doi.org\/10.4103\/NRR.NRR-D-25-00404."},{"key":"2025123112070696073_j_nipt-2025-0016_ref_070","doi-asserted-by":"crossref","unstructured":"Evora, A, Garcia, G, Rubi, A, De Vitis, E, Matos, AT, Vaz, AR, et al.. Exosomes enriched with miR-124-3p show therapeutic potential in a new microfluidic triculture model that recapitulates neuron-glia crosstalk in alzheimer\u2019s disease. Front Pharmacol 2025;16:1474012. https:\/\/doi.org\/10.3389\/fphar.2025.1474012.","DOI":"10.3389\/fphar.2025.1474012"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_071","doi-asserted-by":"crossref","unstructured":"Esteves, M, Abreu, R, Fernandes, H, Serra-Almeida, C, Martins, PAT, Barao, M, et al.. MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for parkinson\u2019s disease. Mol Ther 2022;30:3176\u201392. https:\/\/doi.org\/10.1016\/j.ymthe.2022.06.003.","DOI":"10.1016\/j.ymthe.2022.06.003"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_072","doi-asserted-by":"crossref","unstructured":"Li, Q, Wang, Z, Xing, H, Wang, Y, Guo, Y. Exosomes derived from miR-188-3p-modified adipose-derived mesenchymal stem cells protect parkinson\u2019s disease. Mol Ther Nucleic Acids 2021;23:1334\u201344. https:\/\/doi.org\/10.1016\/j.omtn.2021.01.022.","DOI":"10.1016\/j.omtn.2021.01.022"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_073","doi-asserted-by":"crossref","unstructured":"Provenzano, F, Nyberg, S, Giunti, D, Torazza, C, Parodi, B, Bonifacino, T, et al.. Micro-RNAs shuttled by extracellular vesicles secreted from mesenchymal stem cells dampen astrocyte pathological activation and support neuroprotection in In-Vitro models of ALS. Cells 2022;11. https:\/\/doi.org\/10.3390\/cells11233923.","DOI":"10.3390\/cells11233923"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_074","doi-asserted-by":"crossref","unstructured":"Osorio-Querejeta, I, Carregal-Romero, S, Ayerdi-Izquierdo, A, Mager, I, A, NL, Wood, M, et al.. MiR-219a-5p enriched extracellular vesicles induce OPC differentiation and EAE improvement more efficiently than liposomes and polymeric nanoparticles. Pharmaceutics 2020;12. https:\/\/doi.org\/10.3390\/pharmaceutics12020186.","DOI":"10.3390\/pharmaceutics12020186"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_075","doi-asserted-by":"crossref","unstructured":"Lee, ST, Im, W, Ban, JJ, Lee, M, Jung, KH, Lee, SK, et al.. Exosome-based delivery of miR-124 in a huntington\u2019s disease model. J Mov Disord 2017;10:45\u201352. https:\/\/doi.org\/10.14802\/jmd.16054.","DOI":"10.14802\/jmd.16054"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_076","doi-asserted-by":"crossref","unstructured":"Katsuda, T, Tsuchiya, R, Kosaka, N, Yoshioka, Y, Takagaki, K, Oki, K, et al.. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes. Sci Rep 2013;3:1197. https:\/\/doi.org\/10.1038\/srep01197.","DOI":"10.1038\/srep01197"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_077","doi-asserted-by":"crossref","unstructured":"Jeong, H, Kim, OJ, Oh, SH, Lee, S, Reum Lee, HA, Lee, KO, et al.. Extracellular vesicles released from neprilysin gene-modified human umbilical cord-derived mesenchymal stem cell enhance therapeutic effects in an alzheimer\u2019s disease animal model. Stem Cell Int 2021;2021:5548630. https:\/\/doi.org\/10.1155\/2021\/5548630.","DOI":"10.1155\/2021\/5548630"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_078","doi-asserted-by":"crossref","unstructured":"Zhao, Y, Haney, MJ, Fallon, JK, Rodriguez, M, Swain, CJ, Arzt, CJ, et al.. Using extracellular vesicles released by GDNF-transfected macrophages for therapy of parkinson disease. Cells 2022;11. https:\/\/doi.org\/10.3390\/cells11121933.","DOI":"10.1101\/2022.05.25.493424"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_079","doi-asserted-by":"crossref","unstructured":"Xu, J, Zheng, Y, Wang, L, Liu, Y, Wang, X, Li, Y, et al.. miR-124: a promising therapeutic target for central nervous system injuries and diseases. Cell Mol Neurobiol 2022;42:2031\u201353. https:\/\/doi.org\/10.1007\/s10571-021-01091-6.","DOI":"10.1007\/s10571-021-01091-6"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_080","doi-asserted-by":"crossref","unstructured":"Wu, H, Fan, H, Shou, Z, Xu, M, Chen, Q, Ai, C, et al.. Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1. Int Immunopharmacol 2019;68:204\u201312. https:\/\/doi.org\/10.1016\/j.intimp.2018.12.043.","DOI":"10.1016\/j.intimp.2018.12.043"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_081","doi-asserted-by":"crossref","unstructured":"Wang, H, Moyano, AL, Ma, Z, Deng, Y, Lin, Y, Zhao, C, et al.. miR-219 cooperates with miR-338 in myelination and promotes myelin repair in the CNS. Dev Cell 2017;40:566\u201382 e5. https:\/\/doi.org\/10.1016\/j.devcel.2017.03.001.","DOI":"10.1016\/j.devcel.2017.03.001"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_082","doi-asserted-by":"crossref","unstructured":"Zeng, B, Chen, T, Luo, JY, Zhang, L, Xi, QY, Jiang, QY, et al.. Biological characteristics and roles of noncoding RNAs in milk-derived extracellular vesicles. Adv Nutr 2021;12:1006\u201319. https:\/\/doi.org\/10.1093\/advances\/nmaa124.","DOI":"10.1093\/advances\/nmaa124"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_083","doi-asserted-by":"crossref","unstructured":"Schirmbeck, GH, Sizonenko, S, Sanches, EF. Neuroprotective role of lactoferrin during early brain development and injury through lifespan. Nutrients 2022;14. https:\/\/doi.org\/10.3390\/nu14142923.","DOI":"10.3390\/nu14142923"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_084","doi-asserted-by":"crossref","unstructured":"Ran, L, Shi, J, Lin, Y, Xu, C, Han, Z, Tian, S, et al.. Evaluation of the protective bioactivity and molecular mechanism verification of lactoferrin in an Alzheimer\u2019s mouse model with ulcerative enteritis. J Dairy Sci 2024;107:8796\u2013810. https:\/\/doi.org\/10.3168\/jds.2024-24206.","DOI":"10.3168\/jds.2024-24206"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_085","doi-asserted-by":"crossref","unstructured":"Cheng, CH, Hong, WJ, Li, CN, Huang, YH, Tsai, JH, Huang, CY, et al.. Colostrum-derived exosomal lactoferrin promotes skin fibroblast regeneration by suppressing inflammatory responses. Curr Issues Mol Biol 2025;47. https:\/\/doi.org\/10.3390\/cimb47070549.","DOI":"10.3390\/cimb47070549"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_086","doi-asserted-by":"crossref","unstructured":"O\u2019Kusky, JR, Ye, P, D\u2019Ercole, AJ. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J Neurosci 2000;20:8435\u201342. https:\/\/doi.org\/10.1523\/jneurosci.20-22-08435.2000.","DOI":"10.1523\/JNEUROSCI.20-22-08435.2000"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_087","doi-asserted-by":"crossref","unstructured":"Woodbury, ME, Ikezu, T. Fibroblast growth factor-2 signaling in neurogenesis and neurodegeneration. J Neuroimmune Pharmacol 2014;9:92\u2013101. https:\/\/doi.org\/10.1007\/s11481-013-9501-5.","DOI":"10.1007\/s11481-013-9501-5"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_088","doi-asserted-by":"crossref","unstructured":"Parada, N, Romero-Trujillo, A, Georges, N, Alcayaga-Miranda, F. Camouflage strategies for therapeutic exosomes evasion from phagocytosis. J Adv Res 2021;31:61\u201374. https:\/\/doi.org\/10.1016\/j.jare.2021.01.001.","DOI":"10.1016\/j.jare.2021.01.001"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_089","doi-asserted-by":"crossref","unstructured":"Belhadj, Z, He, B, Deng, H, Song, S, Zhang, H, Wang, X, et al.. A combined \"eat me\/don\u2019t eat me\" strategy based on extracellular vesicles for anticancer nanomedicine. J Extracell Vesicles 2020;9:1806444. https:\/\/doi.org\/10.1080\/20013078.2020.1806444.","DOI":"10.1080\/20013078.2020.1806444"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_090","doi-asserted-by":"crossref","unstructured":"Hermann, DM, Peruzzotti-Jametti, L, Giebel, B, Pluchino, S. Extracellular vesicles set the stage for brain plasticity and recovery by multimodal signalling. Brain : J Neurol 2024;147:372\u201389. https:\/\/doi.org\/10.1093\/brain\/awad332.","DOI":"10.1093\/brain\/awad332"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_091","doi-asserted-by":"crossref","unstructured":"Mun, D, Ryu, S, Choi, H, Kwak, MJ, Oh, S, Kim, Y. Bovine colostrum-derived extracellular vesicles modulate gut microbiota and alleviate atopic dermatitis via the gut-skin axis. Drug Deliv Transl Res 2025. https:\/\/doi.org\/10.1007\/s13346-025-01875-z.","DOI":"10.1007\/s13346-025-01875-z"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_092","doi-asserted-by":"crossref","unstructured":"Ashok, A, Pradeep, H, Soundarya, HS, Aparna, HS. Buffalo colostrum peptide mitigates parkinson\u2019s disease pathophysiology through Cullin-3 inhibition. Bioorg Chem 2024;145:107242. https:\/\/doi.org\/10.1016\/j.bioorg.2024.107242.","DOI":"10.1016\/j.bioorg.2024.107242"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_093","doi-asserted-by":"crossref","unstructured":"Kobayashi, A, Kang, MI, Okawa, H, Ohtsuji, M, Zenke, Y, Chiba, T, et al.. Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol Cell Biol 2004;24:7130\u20139. https:\/\/doi.org\/10.1128\/mcb.24.16.7130-7139.2004.","DOI":"10.1128\/MCB.24.16.7130-7139.2004"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_094","doi-asserted-by":"crossref","unstructured":"Midtgaard, SR, Hansen, MS, Drachmann, N, Geng, X, Blans, KIM, Mobjerg, MMF, et al.. Industrial scale production and characterization of a whey fraction enriched in extracellular vesicle material. J Extracell Biol 2025;4:e70044. https:\/\/doi.org\/10.1002\/jex2.70044.","DOI":"10.1002\/jex2.70044"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_095","unstructured":"GRAS UFaDA. Notice no. GRN 669. [(accessed on 20 February 2023)]. https:\/\/wwwfdagov\/media\/124472\/download.2016."},{"key":"2025123112070696073_j_nipt-2025-0016_ref_096","doi-asserted-by":"crossref","unstructured":"Marar, C, Starich, B, Wirtz, D. Extracellular vesicles in immunomodulation and tumor progression. Nat Immunol 2021;22:560\u201370. https:\/\/doi.org\/10.1038\/s41590-021-00899-0.","DOI":"10.1038\/s41590-021-00899-0"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_043","doi-asserted-by":"crossref","unstructured":"Sadeghi, S, Tehrani, FR, Tahmasebi, S, Shafiee, A, Hashemi, SM. Exosome engineering in cell therapy and drug delivery. Inflammopharmacology 2023;31:145\u201369. https:\/\/doi.org\/10.1007\/s10787-022-01115-7.","DOI":"10.1007\/s10787-022-01115-7"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_097","doi-asserted-by":"crossref","unstructured":"Yu, A, Zhang, T, Duan, H, Pan, Y, Zhang, X, Yang, G, et al.. MiR-124 contributes to M2 polarization of microglia and confers brain inflammatory protection via the C\/EBP-alpha pathway in intracerebral hemorrhage. Immunol Lett 2017;182:1\u201311. https:\/\/doi.org\/10.1016\/j.imlet.2016.12.003.","DOI":"10.1016\/j.imlet.2016.12.003"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_098","doi-asserted-by":"crossref","unstructured":"Liang, C, Zou, T, Zhang, M, Fan, W, Zhang, T, Jiang, Y, et al.. MicroRNA-146a switches microglial phenotypes to resist the pathological processes and cognitive degradation of alzheimer\u2019s disease. Theranostics 2021;11:4103\u201321. https:\/\/doi.org\/10.7150\/thno.53418.","DOI":"10.7150\/thno.53418"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_044","doi-asserted-by":"crossref","unstructured":"Zeng, H, Guo, S, Ren, X, Wu, Z, Liu, S, Yao, X. Current strategies for exosome cargo loading and targeting delivery. Cells 2023;12. https:\/\/doi.org\/10.3390\/cells12101416.","DOI":"10.3390\/cells12101416"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_099","doi-asserted-by":"crossref","unstructured":"Xiong, Y, Shen, T, Lou, P, Yang, J, Kastelic, JP, Liu, J, et al.. Colostrum-derived extracellular vesicles: potential multifunctional nanomedicine for alleviating mastitis. J Nanobiotechnol 2024;22:627. https:\/\/doi.org\/10.1186\/s12951-024-02926-2.","DOI":"10.1186\/s12951-024-02926-2"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_045","doi-asserted-by":"crossref","unstructured":"Ma, R, Kutchy, NA, Wang, Z, Hu, G. Extracellular vesicle-mediated delivery of anti-miR-106b inhibits morphine-induced primary ciliogenesis in the brain. Mol Ther 2023;31:1332\u201345. https:\/\/doi.org\/10.1016\/j.ymthe.2023.03.030.","DOI":"10.1016\/j.ymthe.2023.03.030"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_046","doi-asserted-by":"crossref","unstructured":"Chen, J, Tian, C, Xiong, X, Yang, Y, Zhang, J. Extracellular vesicles: new horizons in neurodegeneration. EBioMedicine 2025;113:105605. https:\/\/doi.org\/10.1016\/j.ebiom.2025.105605.","DOI":"10.1016\/j.ebiom.2025.105605"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_047","doi-asserted-by":"crossref","unstructured":"Hu, G, Brew, BJ. Extracellular vesicle small noncoding RNAs: a window into pathogenesis and diagnosis. AIDS 2023;37:849\u201350. https:\/\/doi.org\/10.1097\/qad.0000000000003517.","DOI":"10.1097\/QAD.0000000000003517"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_048","doi-asserted-by":"crossref","unstructured":"Orihuela, R, McPherson, CA, Harry, GJ. Microglial M1\/M2 polarization and metabolic states. Br J Pharmacol 2016;173:649\u201365. https:\/\/doi.org\/10.1111\/bph.13139.","DOI":"10.1111\/bph.13139"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_100","doi-asserted-by":"crossref","unstructured":"Apodaca, LA, Baddour, AAD, Garcia, CJr., Alikhani, L, Giedzinski, E, Ru, N, et al.. Human neural stem cell-derived extracellular vesicles mitigate hallmarks of alzheimer\u2019s disease. Alzheimers Res Ther 2021;13:57. https:\/\/doi.org\/10.1186\/s13195-021-00791-x.","DOI":"10.1186\/s13195-021-00791-x"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_101","doi-asserted-by":"crossref","unstructured":"Cai, H, Pang, Y, Ren, Z, Fu, X, Jia, L. Delivering synaptic protein mRNAs via extracellular vesicles ameliorates cognitive impairment in a mouse model of alzheimer\u2019s disease. BMC Med 2024;22:138. https:\/\/doi.org\/10.1186\/s12916-024-03359-2.","DOI":"10.1186\/s12916-024-03359-2"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_102","doi-asserted-by":"crossref","unstructured":"Afonso, GJM, Cavaleiro, C, Valero, J, Mota, SI, Ferreiro, E. Recent advances in extracellular vesicles in amyotrophic lateral sclerosis and emergent perspectives. Cells 2023;12. https:\/\/doi.org\/10.3390\/cells12131763.","DOI":"10.20944\/preprints202306.0657.v1"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_049","doi-asserted-by":"crossref","unstructured":"Gao, C, Jiang, J, Tan, Y, Chen, S. Microglia in neurodegenerative diseases: mechanism and potential therapeutic targets. Signal Transduct Targeted Ther 2023;8:359. https:\/\/doi.org\/10.1038\/s41392-023-01588-0.","DOI":"10.1038\/s41392-023-01588-0"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_050","doi-asserted-by":"crossref","unstructured":"Spittau, B. Aging microglia-phenotypes, functions and implications for age-related neurodegenerative diseases. Front Aging Neurosci 2017;9:194. https:\/\/doi.org\/10.3389\/fnagi.2017.00194.","DOI":"10.3389\/fnagi.2017.00194"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_051","doi-asserted-by":"crossref","unstructured":"Wendimu, MY, Hooks, SB. Microglia phenotypes in aging and neurodegenerative diseases. Cells 2022;11. https:\/\/doi.org\/10.3390\/cells11132091.","DOI":"10.3390\/cells11132091"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_103","doi-asserted-by":"crossref","unstructured":"Witwer, KW, Buzas, EI, Bemis, LT, Bora, A, Lasser, C, Lotvall, J, et al.. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles 2013;2. https:\/\/doi.org\/10.3402\/jev.v2i0.20360.","DOI":"10.3402\/jev.v2i0.20360"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_104","doi-asserted-by":"crossref","unstructured":"Gardiner, C, Di Vizio, D, Sahoo, S, Thery, C, Witwer, KW, Wauben, M, et al.. Techniques used for the isolation and characterization of extracellular vesicles: results of a worldwide survey. J Extracell Vesicles 2016;5:32945. https:\/\/doi.org\/10.3402\/jev.v5.32945.","DOI":"10.3402\/jev.v5.32945"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_105","doi-asserted-by":"crossref","unstructured":"Dong, L, Zieren, RC, Horie, K, Kim, CJ, Mallick, E, Jing, Y, et al.. Comprehensive evaluation of methods for small extracellular vesicles separation from human plasma, urine and cell culture medium. J Extracell Vesicles 2020;10:e12044. https:\/\/doi.org\/10.1002\/jev2.12044.","DOI":"10.1002\/jev2.12044"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_052","doi-asserted-by":"crossref","unstructured":"Shao, F, Wang, X, Wu, H, Wu, Q, Zhang, J. Microglia and neuroinflammation: crucial pathological mechanisms in traumatic brain injury-induced neurodegeneration. Front Aging Neurosci 2022;14:825086. https:\/\/doi.org\/10.3389\/fnagi.2022.825086.","DOI":"10.3389\/fnagi.2022.825086"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_053","doi-asserted-by":"crossref","unstructured":"Cherry, JD, Olschowka, JA, O\u2019Banion, MK. Neuroinflammation and M2 microglia: the good, the bad, and the inflamed. J Neuroinflammation 2014;11:98. https:\/\/doi.org\/10.1186\/1742-2094-11-98.","DOI":"10.1186\/1742-2094-11-98"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_106","doi-asserted-by":"crossref","unstructured":"Wiest, EF, Zubair, AC. Generation of current good manufacturing practices-grade mesenchymal stromal cell-derived extracellular vesicles using automated bioreactors. Biology 2025;14. https:\/\/doi.org\/10.3390\/biology14030313.","DOI":"10.3390\/biology14030313"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_054","doi-asserted-by":"crossref","unstructured":"Chen, S, Saeed, A, Liu, Q, Jiang, Q, Xu, H, Xiao, GG, et al.. Macrophages in immunoregulation and therapeutics. Signal Transduct Targeted Ther 2023;8:207. https:\/\/doi.org\/10.1038\/s41392-023-01452-1.","DOI":"10.1038\/s41392-023-01452-1"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_107","doi-asserted-by":"crossref","unstructured":"Thery, C, Witwer, KW, Aikawa, E, Alcaraz, MJ, Anderson, JD, Andriantsitohaina, R, et al.. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018;7:1535750. https:\/\/doi.org\/10.1080\/20013078.2018.1535750.","DOI":"10.1080\/20013078.2018.1535750"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_108","doi-asserted-by":"crossref","unstructured":"Welsh, JA, Goberdhan, DCI, O\u2019Driscoll, L, Buzas, EI, Blenkiron, C, Bussolati, B, et al.. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 2024;13:e12404. https:\/\/doi.org\/10.1002\/jev2.12404.","DOI":"10.1002\/jev2.12451"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_109","doi-asserted-by":"crossref","unstructured":"Singh, M, Mazaheri-Tehrani, G, Martin-Fabiani, I, Davies, OG. Electroporation induced changes in extracellular vesicle profile. Drug Deliv 2025;32:2562224. https:\/\/doi.org\/10.1080\/10717544.2025.2562224.","DOI":"10.1080\/10717544.2025.2562224"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_110","doi-asserted-by":"crossref","unstructured":"Xu, G, Jin, J, Fu, Z, Wang, G, Lei, X, Xu, J, et al.. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Targeted Ther 2025;10:255. https:\/\/doi.org\/10.1038\/s41392-025-02312-w.","DOI":"10.1038\/s41392-025-02312-w"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_111","doi-asserted-by":"crossref","unstructured":"Ferreira, D, Moreira, JN, Rodrigues, LR. New advances in exosome-based targeted drug delivery systems. Crit Rev Oncol Hematol 2022;172:103628. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103628.","DOI":"10.1016\/j.critrevonc.2022.103628"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_112","doi-asserted-by":"crossref","unstructured":"Han, Y, Jones, TW, Dutta, S, Zhu, Y, Wang, X, Narayanan, SP, et al.. Overview and update on methods for cargo loading into extracellular vesicles. Processes 2021;9. https:\/\/doi.org\/10.3390\/pr9020356.","DOI":"10.3390\/pr9020356"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_113","doi-asserted-by":"crossref","unstructured":"Stawarska, A, Bamburowicz-Klimkowska, M, Runden-Pran, E, Dusinska, M, Cimpan, MR, Rios-Mondragon, I, et al.. Extracellular vesicles as next-generation diagnostics and advanced therapy medicinal products. Int J Mol Sci 2024;25. https:\/\/doi.org\/10.3390\/ijms25126533.","DOI":"10.3390\/ijms25126533"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_114","doi-asserted-by":"crossref","unstructured":"Mussin, NM, Zhilisbayeva, KR, Baspakova, A, Kurmanalina, MA, Tamadon, A. Umbrella review of mesenchymal stem cell-derived extracellular vesicles in preclinical models: therapeutic efficacy across diverse conditions. Front Cell Dev Biol 2025;13:1655623. https:\/\/doi.org\/10.3389\/fcell.2025.1655623.","DOI":"10.3389\/fcell.2025.1655623"},{"key":"2025123112070696073_j_nipt-2025-0016_ref_115","doi-asserted-by":"crossref","unstructured":"Zhao, H, Shang, Q, Pan, Z, Bai, Y, Li, Z, Zhang, H, et al.. Exosomes from adipose-derived stem cells attenuate adipose inflammation and obesity through polarizing M2 macrophages and beiging in white adipose tissue. Diabetes 2018;67:235\u201347. https:\/\/doi.org\/10.2337\/db17-0356.","DOI":"10.2337\/db17-0356"}],"container-title":["NeuroImmune Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2025-0016\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2025-0016\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:07:45Z","timestamp":1767182865000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/nipt-2025-0016\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":115,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,25]]},"published-print":{"date-parts":[[2025,12,31]]}},"alternative-id":["10.1515\/nipt-2025-0016"],"URL":"https:\/\/doi.org\/10.1515\/nipt-2025-0016","relation":{},"ISSN":["2750-6665"],"issn-type":[{"value":"2750-6665","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}